[144] Ares Management Corporation SEC Filing
Ares Management Corporation (ARES) Form 144 notice reports a proposed sale of 533,796 common shares through Morgan Stanley Smith Barney on 08/18/2025 with an aggregate market value of $100,236,212.88. The shares were acquired as Founders Shares from the issuer on 05/02/2014. The filing also lists 10b5-1 sales by ATTICUS ENTERPRISES LLC during the past three months on 05/19/2025, 05/20/2025, 05/21/2025, and 08/15/2025 with individual gross proceeds shown. The filer certifies no undisclosed material adverse information and references Rule 10b5-1 trading plan language.
- Full regulatory disclosure of proposed sale including broker, share count, and aggregate market value
- Inclusion of 10b5-1 sales history for transparency about recent insider dispositions
- Acquisition details provided (Founders Shares acquired 05/02/2014 from the issuer)
- Large aggregate market value of proposed sale: $100,236,212.88, indicating significant insider liquidity
- Multiple recent 10b5-1 sales by ATTICUS ENTERPRISES LLC in May and August 2025 with substantial gross proceeds
Insights
TL;DR: Insider notice discloses a substantial proposed sale and recent systematic 10b5-1 transactions, providing transparency but signaling share disposition.
The filing explicitly details a proposed sale of 533,796 common shares with an aggregate market value of $100,236,212.88 to be executed through Morgan Stanley Smith Barney on 08/18/2025. It confirms the shares were acquired as founders shares on 05/02/2014. The record of multiple 10b5-1 sales by ATTICUS ENTERPRISES LLC in May and August 2025 and the certification regarding material nonpublic information are important for investors monitoring insider liquidity and planned dispositions.
TL;DR: Filing shows standard Rule 144 notice and 10b5-1 activity; it is a routine disclosure of insider share sales.
The notice follows Rule 144 requirements, naming broker, share amounts, and acquisition details. It documents founders shares acquired from the issuer on 05/02/2014 and references prior 10b5-1 executions with specific dates and gross proceeds. The signature representation that no material undisclosed information exists is included, consistent with compliance norms for planned insider sales.